Towards Healthcare
Sandhoff Disease Treatment Market Size Expands USD 274.95 Million in 2025

Sandhoff Disease Treatment Market Expands in 2025 with Strong Pipeline, Targeting USD 456.42 Million by 2034

Projections indicate that, the global sandhoff disease treatment market will increase from USD 260 million in 2024 to USD 456.42 million by 2034, experiencing a CAGR of 5.75% over the next 10 years. The Sandhoff disease treatment market is expanding due to increasing demand for treatment options as well as rising awareness. North America led the market due to increasing awareness.

Content

  • Insight Code: 5829
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The Sandhoff disease treatment market is projected to reach USD 456.42 million by 2034, growing at a CAGR of 5.75% from 2024 to 2034.

North America is currently leading the Sandhoff disease treatment market due to increasing awareness.

The Sandhoff disease treatment market includes six segments such as by therapy typeShape, Picture, by disease form, by drug type, by route of administration, by end user, and by region.

Some key players include Denali Therapeutics, Sio Gene Therapies, Taysha Gene Therapies, and Passage Bio.

A rare lysosomal storage disease that causes progressive neurodegeneration is known as Sandhoff disease.

Treatments such as supportive therapies, experimental gene therapies, enzyme replacement trials, substrate reduction therapies, and symptomatic management are available for Sandhoff disease.

American Society of Gene and Cell Therapy (ASGCT), Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions